Children to Adults Mental and Psychosomatic Health Study (CAMPS)

Cognitive Function Clinical Trial

Official title:

Children to Adults Mental and Psychosomatic Health Study (CAMPS): A Longitudinal Cohort Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05621278
• Other study ID #: CAMPS
• Status: Recruiting
• Start date: September 11, 2022
• Est. completion date: December 31, 2026

Study information

• Verified date: April 2024
• Source: Peking University
• Contact: Zang Yinyin, PhD
• Phone: +86 15553201610
• Email: yinyin.zang[@]pku.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study titled the Children to Adults Mental and Psychosomatic Health Study (CAMPS), aims to explore the interplay between mental health, psychosomatic factors, and adverse childhood experiences (ACE) across a broad age range, from school-age children to adults in China. The study will involve participants from various educational settings, including teachers, students, and parents, who will be recruited through schools. The assessment methodology will combine validated psychometric scales and behavioral experiments to comprehensively evaluate mental and physical health aspects and the impact of ACEs. This integrative approach is designed to illuminate the complex relationships between psychological well-being, somatic symptoms, and early life stressors across different life stages.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400000
• Est. completion date: December 31, 2026
• Est. primary completion date: December 31, 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 9 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Students from 5 grade to 12 grade, their parents and teachers

2. able to read, answer questionnaires and complete experiments. Exclusion Criteria: a. Students who suspend schooling.

Related Conditions & MeSH terms

• Cognitive Function
• Mental Health Wellness

Locations

Country	Name	City	State
China	Peking University	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Irritability	A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85). A higher score represents higher irritability.	1 month
Primary	Alexithymia	A 36-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 36 to 180). A higher score represents more severe alexithymia.	1 month
Primary	Depression for adults	The 9-item patient health questionnaire (PHQ-9) for adults (score from 0 to 3, and total score varies from 0 to 27). A higher score represents worse depression symptoms.	2 weeks
Primary	Depression	Children's depression inventory (CDI) for adolescents and children (score from 0 to 2, and total score vary from 0 to 54). A higher score represents worse depression symptoms.	2 weeks
Primary	Generalized anxiety disorder	The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21). A higher score represents worse anxiety symptoms.	2 weeks
Primary	Anxiety and depression for adolescents and children	The Revised Child Anxiety and Depression Scale (RCADS) for adolescents and children (scored from 0 to 3, and total score from 0 to 75). A higher score represents worse anxiety and depression symptoms.	2 weeks
Primary	PTSD for adults	The PTSD Symptoms Scale-Interview for DSM-5 (PSSI-5) for adults (score from 0 to 4, and total scores vary from 0 to 80). A higher score represents worse PTSD symptoms.	1 month
Primary	PTSD for adolescents and children	The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80). A higher score represents worse PTSD symptoms.	1 month
Primary	NSSI	The non-suicidal self-injury assessment tool (NSSI-AT-Severity) for adolescents and children (total scores vary from 5 to 16). A higher score represents a worse self-injury situation.	1 year
Primary	Suicide	The suicidal behaviors questionnaire-revised (SBQ-R) for adolescents and children (total scores vary from 3 to 18). A higher score represents a higher suicide risk.	1 year
Primary	Emotion recognition	The Morph task for adolescents to examine the emotion recognition capability.	Half year
Primary	Excutive function	The Go/Nogo task for adolescents is to examine inhibition function.	Half year
Primary	Adverse Childhood Experiences (ACE)	A questionnaire measuring adverse childhood experiences with 26 items.	each year